GSK PLC CEDEAR EACH REPR 1/4 ADR (USD)GSK PLC CEDEAR EACH REPR 1/4 ADR (USD)GSK PLC CEDEAR EACH REPR 1/4 ADR (USD)

GSK PLC CEDEAR EACH REPR 1/4 ADR (USD)

No trades
See on Supercharts

GSKD fundamentals

An in-depth look to GSK PLC CEDEAR EACH REPR 1/4 ADR (USD) operating, investing, and financing activities

GSKD free cash flow for Q3 24 is 2.16 B USD. For 2023, GSKD free cash flow was 2.28 B USD and operating cash flow was 2.87 B USD.

Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth